Hyperglycemia effect on coronary disease in patients with metabolic syndrome evaluated by intracoronary ultrasonography

INTRODUCTION: Metabolic syndrome (MS) is characterized by dyslipidemia, central obesity, hypertension and hyperglycemia. However, type 2 diabetes mellitus (T2DM) may or may not be present in metabolic syndrome. MS and T2DM are considered important cardiovascular risk factors, but the role of hypergl...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Bonamichi, Beatriz Dal Santo Francisco, Parente, Erika Bezerra, Campos, Ana Carolina Noronha, Cury, Adriano Namo, Salles, João Eduardo Nunes
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5302811/
https://ncbi.nlm.nih.gov/pubmed/28187174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0171733
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia